XenoPort
Latest round
- Series D
Last raised
- Dec 2004
Total raised
- $152M
Investors
- 19
About XenoPort
XenoPort Inc. is a biopharmaceutical company focused on developing novel therapeutics to improve the treatment of neurological diseases.Founded in 1999 in Santa Clara, US, XenoPort Inc. specializes in developing new medications for neurological conditions. The company transitioned its strategy with a focus on innovative drug delivery technologies. The company has engaged in a total of 9 deals, with its last deal occurring on June 1, 2005.XenoPort Inc. develops and commercializes promising drugs aimed at treating neurological disorders. The company combines scientific research with advanced drug delivery systems to create therapeutics that meet unmet medical needs.Looking forward, XenoPort Inc. The company aims to expand into new geographic markets, specifically targeting regions in North America and Europe by 2025.
Who invested in XenoPort
19 investors across 5 rounds
See all investors in XenoPort
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about XenoPort
Who invested in XenoPort?
XenoPort has 19 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has XenoPort raised?
XenoPort has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did XenoPort last raise money?
XenoPort's most recent round on record is a Series D, in Dec 2004.
What does XenoPort do?
XenoPort is a biotechnology company.
Where is XenoPort headquartered?
XenoPort is headquartered in Santa Clara, US.
Which VCs invest in companies like XenoPort?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at XenoPort's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like XenoPort? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.